Acute Intervention to Reduce Distress Following Sexual Assault

Prevention of Post-Rape Psychopathology and Drug Abuse

Status

Completed

Phases

Phase 1Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01622855

Enrollment

442

Registered

2012-06-19

Start date

1997-03-31

Completion date

2005-09-30

Last updated

2015-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Abuse, Drug Use, Posttraumatic Stress Disorder

Keywords

Rape, Secondary prevention, Intervention

Brief summary

The purpose of this study was to evaluate whether a brief intervention in video format delivered in the post assault medical exam setting and including education about assault reactions and instruction in and modeling of successful coping strategies would reduce post assault drug use or abuse and PTSD symptoms as compared to standard care.

Detailed description

The intervention being evaluated was shown at the time of the post assault medical exam and includes two main components: preparation for the medical exam; and information about and modelling of coping strategies that may help women cope in the aftermath of assault. The intervention content is delivered via video. Intervention and standard care groups were compared with regard to measures of substance use and abuse and symptoms of PTSD and other potentially comorbid problems including symptoms of depression or other anxiety.

Interventions

BEHAVIORALPPRS

Video including psycho-education and modeling of adaptive behavioral coping strategies for use post-assault.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

FEMALE

Age

14 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Seeking medical care after recent sexual assault

Exclusion criteria

* Active psychosis * Active suicidality * Cognitive impairment * Non-English speaking * Severe injury

Design outcomes

Primary

Measure	Time frame	Description
Frequency of specific drug use	14 days	Number of days use of specific drugs in preceding 14 days at 6 week, 3 and 6 month follow-ups

Secondary

Measure	Time frame	Description
Specific Drug Abuse	1.5, 3, 6 months	Criteria for DSM-IV substance abuse based on structured interview
PSS-SR	2 weeks	Measure of PTSD symptoms

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026